Solidago compositum Soluzione iniettabile (s. c. i. m.) Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

solidago compositum soluzione iniettabile (s. c. i. m.)

ebi-pharm ag - acidum arsenicosum (hab) d28 (hab sv), apisinum (hab) d8 (hab sv), argentum nitricum (hab) d6, berberis vulgaris (hab) d4, baptisia tinctoria (hab) d4, barosma ex foliis d8 (hab 4a), capsicum annuum (hab) d6, chondrodendron (hab) d6, colibacillinum nosode d13 (hab 44), coxsackie virus a9 nosode d8 (hab 44), cuprum sulfuricum (hab) d6 (hab 5a), equisetum hiemale ex planta tota d4 (hab 2a), hepar sulfuris (hab) d10, hydrargyrum bichloratum (hab) d8 (hab 5a), lytta vesicatoria (hab) d6, natrium pyruvicum d10 (hab 5a), orthosiphon aristatus ex herba d6 (hab 4a), pyelon suis d10 (hab 42a), pyrogenium-nosode (hab) d198, smilax (hab) d6, solidago virgaurea (hab) d3, terebinthina laricina (hab) d6, ureter suis d10 (hab 42a), urethra suis d10 (hab 42a), vesica urinaria suis d8 (hab 42a) - soluzione iniettabile (s. c. i. m.) - acidum arsenicosum (hab) d28 (hab sv) 22.0 mg, apisinum (hab) d8 (hab sv) 22.0 mg, argentum nitricum (hab) d6 22.0 mg, berberis vulgaris (hab) d4 22.0 mg, baptisia tinctoria (hab) d4 22.0 mg, barosma ex foliis d8 (hab 4a) 22.0 mg, capsicum annuum (hab) d6 22.0 mg, chondrodendron (hab) d6 22.0 mg, colibacillinum nosode d13 (hab 44) 22.0 mg, coxsackie virus a9 nosode d8 (hab 44) 22.0 mg, cuprum sulfuricum (hab) d6 (hab 5a) 22.0 mg, equisetum hiemale ex planta tota d4 (hab 2a) 22.0 mg, hepar sulfuris (hab) d10 22.0 mg, hydrargyrum bichloratum (hab) d8 (hab 5a) 22.0 mg, lytta vesicatoria (hab) d6 22.0 mg, natrium pyruvicum d10 (hab 5a) 22.0 mg, orthosiphon aristatus ex herba d6 (hab 4a) 22.0 mg, pyelon suis d10 (hab 42a) 22.0 mg, pyrogenium-nosode (hab) d198 22.0 mg, smilax (hab) d6 22.0 mg, solidago virgaurea (hab) d3 22.0 mg, terebinthina laricina (hab) d6 22.0 mg, ureter suis d10 (hab 42a) 22.0 mg, urethra suis d10 (hab 42a) 22.0 mg, vesica urinaria suis d8 (hab 42a) 22.0 mg, natrii chloridum corresp. natrium 7,60 mg, aqua ad iniectabile, pro vitro 2.2 ml. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - farmaci omeopatici